María Villa-Morales
12PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 09, 2026
Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Aug 27, 2025
Improved identification of T-ALL paediatric patients with low MRD but poor prognosis using a transcriptional signature.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Jul 20, 2024
PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Sep 15, 2023
The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro
|Jun 28, 2023
Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.María Villa-Morales, Laura Pérez-Gómez, Eduardo Pérez-Gómez
|Jun 02, 2023
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.Antonio Lahera, Laura Vela-Martín, Pilar López-Nieva
Pageof 2
Frequent Collaborators
8 joint publications
José Fernández-Piqueras
5 joint publications
Antonio Lahera
4 joint publications
Pilar López-Nieva
4 joint publications
Laura Vela-Martín
4 joint publications
Eduardo Pérez-Gómez
3 joint publications
José Luis Marín-Rubio
3 joint publications
José L López-Lorenzo
2 joint publications
Agustín F Fernández
2 joint publications
Pablo Fernández-Navarro
2 joint publications
Isabel Sastre
